,,ii  #aagth ,,congress  #b;d ,session  
,s4 #ceaf  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,january #ah1  
#bjbb,mr4 ,sasse introduced the         
following bill2 which was read twice and
 referred to the ,committee on ,health1 
,education1 ,labor1 and ,pensions  ,a   
,,bill  ,to require the ,secretary of   
,health and ,human ,services to provide 
emergency use authorization with respect
 to certain ,,covid-#ai diagnostic tests
 approved for use in the ,european      
,union4  #a4 ,short title ,this ,act may
 be cited as the ,increase ,access to   
,,covid ,testing ,act4  #b4 ,emergency  
use approval of certain ,,covid-#ai     
tests  7a7 ,in general ,for the duration
 of the public health emergency declared
 under section #cai of the ,public      
,health ,service ,act 7#db ,u4,s4,c4    
#bdg;d7 with respect to ,,covid-#ai1 the
 ,secretary of ,health and ,human       
,services shall authorize the           
introduction into interstate commerce1  
pursuant to section #efd of the ,federal

 ,food1 ,drug1 and ,cosmetic ,act 7#ba  
,u4,s4,c4 #cfj;bbb-#c71 without regard  
for any specific criteria under         
subsection 7c77#b7 of such section1 of  
any antigen diagnostic test to detect   
,,sars-,co,v-#b that is described in    
subsection 7b71 upon request by the     
manufacturer under such section #efd4   
7b7 ,tests described ,an antigen        
diagnostic test to detect               
,,sars-,co,v-#b described in this       
subsection is such a test-- 7#a7 that is
 included on the common list of         
,,covid-#ai rapid antigen tests of the  
,european ,commission                   
,directorate-,general for ,health and   
,food ,safety2 and  7#b7 for which the  
emergency use authorization request is  
for an at-home1 or other non-laboratory 
site1 use1 without a prescription4  7c7 
,terms of authorization  7#a7 ,in       
general ,a diagnostic test authorized as
 described in subsection 7a7 shall be   
subject to the same terms and           
requirements as other products          

authorized under section #efd of the    
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cfj;bbb-#c74  7#b7 
,change in status in the ,,eu ,in the   
case of an antigen diagnostic test      
authorized as described in subsection   
7a71 if the ,european ,commission       
,directorate-,general for ,health and   
,food ,safety removes such test from the
 common list described in subsection    
7b77#a71 the ,secretary of ,health and  
,human ,services1 not later than #cj    
days after such removal from the common 
list1 shall conduct a review of the test
 to determine whether the emergency use 
authorization under section #efd of the 
,federal ,food1 ,drug1 and ,cosmetic    
,act 7#ba ,u4,s4,c4 #cfj;bbb-#c7 should 
continue4